Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Molecular analysis of vascular smooth muscle cells from patients with giant cell arteritis: Targeting endothelin-1 receptor to control proliferation.

Régent A, Ly KH, Groh M, Khifer C, Lofek S, Clary G, Chafey P, Baud V, Broussard C, Federici C, Labrousse F, Mesturoux L, Le Jeunne C, Vidal E, Brezin A, Witko-Sarsat V, Guillevin L, Mouthon L.

Autoimmun Rev. 2017 Apr;16(4):398-406. doi: 10.1016/j.autrev.2017.02.006. Epub 2017 Feb 14. Review.

PMID:
28232168
2.

Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update.

Nesher G, Breuer GS.

Rambam Maimonides Med J. 2016 Oct 31;7(4). doi: 10.5041/RMMJ.10262. Review.

3.

The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.

Jakobsson K, Jacobsson L, Mohammad AJ, Nilsson JÅ, Warrington K, Matteson EL, Turesson C.

BMC Musculoskelet Disord. 2016 Aug 24;17(1):363. doi: 10.1186/s12891-016-1225-2.

4.

Involvement and prognosis value of CD8(+) T cells in giant cell arteritis.

Samson M, Ly KH, Tournier B, Janikashvili N, Trad M, Ciudad M, Gautheron A, Devilliers H, Quipourt V, Maurier F, Meaux-Ruault N, Magy-Bertrand N, Manckoundia P, Ornetti P, Maillefert JF, Besancenot JF, Ferrand C, Mesturoux L, Labrousse F, Fauchais AL, Saas P, Martin L, Audia S, Bonnotte B.

J Autoimmun. 2016 Aug;72:73-83. doi: 10.1016/j.jaut.2016.05.008. Epub 2016 May 25.

PMID:
27236507
5.

Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study.

Restuccia G, Boiardi L, Cavazza A, Catanoso M, Macchioni P, Muratore F, Cimino L, Aldigeri R, Crescentini F, Pipitone N, Salvarani C.

Medicine (Baltimore). 2016 May;95(19):e3524. doi: 10.1097/MD.0000000000003524.

6.

Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis.

Muratore F, Boiardi L, Cavazza A, Aldigeri R, Pipitone N, Restuccia G, Bellafiore S, Cimino L, Salvarani C.

J Autoimmun. 2016 May;69:94-101. doi: 10.1016/j.jaut.2016.03.005. Epub 2016 Mar 20.

PMID:
27009904
7.

Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis.

Ciccia F, Rizzo A, Guggino G, Cavazza A, Alessandro R, Maugeri R, Cannizzaro A, Boiardi L, Iacopino DG, Salvarani C, Triolo G.

Rheumatology (Oxford). 2015 Sep;54(9):1596-604. doi: 10.1093/rheumatology/kev102. Epub 2015 Apr 9.

PMID:
25862016
8.

Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis.

Chen H, Zheng D, Ambadapadi S, Davids J, Ryden S, Samy H, Bartee M, Sobel E, Dai E, Liu L, Macaulay C, Yachnis A, Weyand C, Thoburn R, Lucas A.

PLoS One. 2015 Feb 6;10(2):e0115482. doi: 10.1371/journal.pone.0115482. eCollection 2015.

9.

The effect of temporal artery biopsy on the treatment of temporal arteritis.

Le K, Bools LM, Lynn AB, Clancy TV, Hooks WB 3rd, Hope WW.

Am J Surg. 2015 Feb;209(2):338-41. doi: 10.1016/j.amjsurg.2014.07.007. Epub 2014 Oct 13.

PMID:
25457237
10.

The diagnosis and classification of giant cell arteritis.

Nesher G.

J Autoimmun. 2014 Feb-Mar;48-49:73-5. doi: 10.1016/j.jaut.2014.01.017. Epub 2014 Jan 21. Review.

PMID:
24461386
11.

Temporal arteritis in a young patient.

Akalin T, Kaya FC, Tekin Y.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S59-61. Epub 2013 Oct 17.

PMID:
24143876
12.

Are IL-10+ regulatory Th17 cells implicated in the sustained response to glucocorticoid treatment in patients with giant cell arteritis? Comment on the paper of Espigol-Frigole et al.

Samson M, Audia S, Janikashvili N, Bonnotte B.

Ann Rheum Dis. 2013 May;72(5):e3. doi: 10.1136/annrheumdis-2013-203439. Epub 2013 Mar 8. No abstract available.

PMID:
23475980
13.

Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis.

Quick V, Kirwan JR.

J R Coll Physicians Edinb. 2012;42(4):341-9. doi: 10.4997/JRCPE.2012.413.

PMID:
23240123
14.

[Pathogenesis of giant cell arteritis].

Guo ZY, Xu JZ, Liu ZJ.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):641-4. doi: 10.3760/cma.j.issn.0529-5807.2012.09.019. Review. Chinese. No abstract available.

PMID:
23157840
15.

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.

Espígol-Frigolé G, Corbera-Bellalta M, Planas-Rigol E, Lozano E, Segarra M, García-Martínez A, Prieto-González S, Hernández-Rodríguez J, Grau JM, Rahman MU, Cid MC.

Ann Rheum Dis. 2013 Sep 1;72(9):1481-7. doi: 10.1136/annrheumdis-2012-201836. Epub 2012 Sep 19.

PMID:
22993227
16.

Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab.

Besada E, Nossent JC.

Clin Rheumatol. 2012 Aug;31(8):1263-5. doi: 10.1007/s10067-012-2007-3. Epub 2012 Jun 2. Review.

PMID:
22661052
17.

Annular elastolytic giant cell granuloma associated with temporal arteritis leading to blindness.

Shoimer I, Wismer J.

J Cutan Med Surg. 2011 Sep-Oct;15(5):293-7.

PMID:
21962191
18.

Isolated facial palsy and ophthalmoplegia--first symptoms of a cerebral granulomatous vasculitis with giant cells--a diagnostic challenge.

Broussalis E, Luthringshausen G, Kunz AB, McCoy M, Weiss S, Killer-Oberpfalzer M, Trinka E, Kraus J.

Clin Neurol Neurosurg. 2011 Oct;113(8):686-8. doi: 10.1016/j.clineuro.2011.04.007. Epub 2011 May 25. No abstract available.

PMID:
21616584
19.

Primary angiitis of the central nervous system with diffuse cerebral mass effect and giant cells.

Kinsella JA, O'Brien W, Mullins GM, Brewer J, Whyte S.

J Clin Neurosci. 2010 May;17(5):674-6. doi: 10.1016/j.jocn.2009.09.031. Epub 2010 Mar 19.

PMID:
20303761
20.

Th17 and Th1 T-cell responses in giant cell arteritis.

Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM.

Circulation. 2010 Feb 23;121(7):906-15. doi: 10.1161/CIRCULATIONAHA.109.872903. Epub 2010 Feb 8.

Supplemental Content

Loading ...
Support Center